BioCentury | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

...treat breast cancer. Chinese Academy of Sciences Distillery Therapeutics Cancer; colorectal cancer; melanoma E. coli lipid A biosynthesis (kdo)2-(lauroyl)-lipid IVA acyltransferase ( E. coli msbB...
...E. coli msbB) Mouse studies suggest bacterial outer membrane vesicles (OMVs) derived from E. coli with E. coli msbB...
BioCentury | Oct 17, 2017
Distillery Therapeutics

Cancer

...membrane vesicles (OMVs) could help treat cancer. The OMVs were derived from E. coli with E. coli msbB...
...genetically engineering versions of the OMVs to have more potent anti-tumor effects. TARGET/MARKER/PATHWAY: E. coli lipid A biosynthesis (kdo)2-(lauroyl)-lipid IVA acyltransferase ( E. coli msbB...
...South Korea email: aglaia@postech.ac.kr CONTACT: Yong Song Gho, same affiliation as above email: ysgho@postech.ac.kr Karen Tkach Tuzman E. coli lipid A biosynthesis (kdo)2-(lauroyl)-lipid IVA acyltransferase (E. coli msbB) Cancer...
Items per page:
1 - 2 of 2